SCHEMBL7035776

SCHEMBL7035776

Oc1ccc(Oc2cccc(-c3ccccc3)c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.69
▸ NR1H2 P55055 1/20 0.69
▸ BAX Q07812 1/20 0.69
▸ FFAR1 O14842 2/20 0.55
▸ FFAR4 Q5NUL3 2/20 0.55
▸ ESR1 P03372 4/20 0.54
▸ ESR2 Q92731 3/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ MMP3 P08254 1/20 0.52
▸ BCL2L1 Q07817 1/20 0.52
▸ ABL1 P00519 2/20 0.51
▸ ABCB1 P08183 2/20 0.51
▸ BCR P11274 2/20 0.51
▸ HSD17B1 P14061 1/20 0.50
▸ HSD17B2 P37059 1/20 0.50
▸ GSTP1 P09211 1/20 0.48
▸ AKR1C3 P42330 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27090262 0.94 ESR1 (0.61) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL21311877 0.94 ESR1 (0.61) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL27090234 0.94 LTA4H (0.64) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL9292956 0.89 HSD17B1 (0.68) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL21311926 0.89 HSD17B1 (0.61) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL10453614 0.88 FFAR4 (0.61) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL19891793 0.88 FFAR4 (0.61) LTA4HNR1H2BAXFFAR1FFAR4
SCHEMBL11426529 0.88 LTA4H (0.82) LTA4HNR1H2BAXESR1ESR2
SCHEMBL9588710 0.88 LTA4H (0.82) LTA4HNR1H2BAXESR1ESR2
SCHEMBL4536542 0.88 LTA4H (0.60) LTA4HNR1H2BAXFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944636-B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS LILLY CO ELI (US) 2003-03-19 — — EP disclosed
EP-0946495-B1 PHENYL ACETAMIDES AS SPLA2 INHIBITORS LILLY CO ELI (US) 2002-07-24 — — EP disclosed
US-6353128-B1 FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK. ELI LILLY AND COMPANY 2002-03-05 — — US disclosed
EP-0946495-A4 PHENYL ACETAMIDES AS SPLA2 INHIBITORS LILLY CO ELI (US) 2000-04-12 — — EP disclosed
EP-0946495-A1 PHENYL ACETAMIDES AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1999-10-06 — — EP disclosed
US-5916922-A FOR INHIBITING HUMAN NON-PANCREATIC SECRETORY PHOSPHOLIPASE A2 ELI LILLY AND COMPANY (US) 1999-06-29 — — US disclosed
WO-1998024756-A1 PHENYL ACETAMIDES AS SPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1998-06-11 — — WO disclosed
Send feedback